Review Article
Volume 8 Issue 3 - 2020
Application of Nanoparticles for Nano Medicine
Rassol Housen Pure* and Mahdi Ghorbani Mazraehkhalfi
Department of Basic Science, Faculty of Biology, Payame Noor University, Iran
*Corresponding Author: Rassol Housen Pure, Department of Basic Science, Faculty of Biology, Payame Noor University, Iran.
Received: January 09, 2020; Published: February 28, 2020




Abstract

Firstly, the idea of using nanotechnology in medicine was developed from a creative imagination which based on that small machine men can be designed and after entering these machines into the human body they are used to perform molecular restorations at the cellular level. Also, in this research we introduce common nanoparticles, fullerenes, nano micelles solid lipid nanoparticles, metal nanoparticles, polymeric nanoparticles, dendrimers, nano shells, quantum dots, nano liposomes. In this research, the features of particles and know structures and applicable in drug delivery are mentioned. The purpose of this research is to introduce the application of nanoparticles for Nano medicine for excellence in nano medicine development.

Keywords: Nanoparticles; Dendrimers; Solid Lipid Nanoparticles; Nano Shells

References

  1. Lewenstein., et al. “Nanotechnology in the media: A preliminary analysis. Nanotechnology: Societal Implications II: Individual Perspectives. Dordrecht. Springer (2007): 258-265.
  2. Drexler., et al. “Unbounding the future: the nanotechnology revolution” (1991).
  3. Freitas RA. “Nanomedicine, volume I: basic capabilities”. Volume 1: Landes Bioscience Georgetown, TX (1999).
  4. Freitas Jr RA. “What is nanomedicine?” Nanomedicine: Nanotechnology, Biology and Medicine 1.1 (2005): 2-9.
  5. Feynman RP. “There's plenty of room at the bottom”. California Institute of Technology, Engineering and Science magazine (1960).
  6. Krätschmer W., et al. “Solid C60: a new form of carbon”. Nature 347.6291 (1990): 354.
  7. Alekseyev N and G Dyuzhev. “Fullerene formation in an arc discharge”. Carbon 41.7 (2003): 1343-1348.
  8. Howard JB., et al. “Fullerenes C60 and C70 in flames”. Nature 352.6331 (1991): 139.
  9. Goel A and JB Howard. “Reaction rate coefficient of fullerene (C60) consumption by soot”. Carbon 41.10 (2003): 1949-1954.
  10. Boorum MM., et al. “Groundwork for a rational synthesis of C60: cyclodehydrogenation of a C60H30 polyarene”. Science 294.5543 (2001): 828-831.
  11. Scott LT., et al. “A rational chemical synthesis of C60”. Science 295.5559 (2001): 1500-1503.
  12. Hirsch A. “The chemistry of the fullerenes: an overview”. Angewandte Chemie International Edition in English 32.8 (1993): 1138-1141.
  13. Seetharamappa J., et al. “Carbon nanotubes”. Electrochemical society interface (2006).
  14. Cox B and J Hill. “A polyhedral model for carbon nanotubes” (2007).
  15. Kagan V., et al. “Direct and indirect effects of single walled carbon nanotubes on RAW 264.7 macrophages: role of iron”. Toxicology Letters 165.1 (2006): 88-100.
  16. Periyakaruppan A., et al.” Uranium induces oxidative stress in lung epithelial cells”. Archives of toxicology 81.6 (2007): 389-395.
  17. Wu G., et al. “Remotely triggered liposome release by near-infrared light absorption via hollow gold nanoshells”. Journal of the American Chemical Society 130.26 (2008): 8175-8177.
  18. Papahadjopoulos D. “Liposomes and their uses in biology and medicine”. Annals of the New York Academy of Sciences (1978): 308-324.
  19. Bangham AD. “Surrogate cells or Trojan horses. The discovery of liposomes”. BioEssays 17.12 (1995): 1081-1088.
  20. Stoyanov ES. “New type of nanoparticles, nanomicelles formed in water-saturated organic solutions of HFeCl4 and HClO4: Composition, structure and properties”. Journal of the Chemical Society, Faraday Transactions 94.18 (1998): 2803-2812.
  21. Muller RH. “Solid lipid nanoparticles (SLN)-an alternative colloidal carrier system for controlled drug delivery”. The European Journal of Pharmaceutics and Biopharmaceutics 41 (1995): 62-69.
  22. Siekmann B and K Westesen. “Submicron-sized parenteral carrier systems based on solid lipids”. Pharmaceutical and Pharmacological Letters 1.3 (1992): 123-126.
  23. Muller R. “Arzneistofftrager aus festen lipidteilchen (Feste Lipidnanospharen (SLN))”. European Patent Office B1 (1996).
  24. Faraji AH and P Wipf. “Nanoparticles in cellular drug delivery”. Bioorganic and Medicinal Chemistry 17.8 (2009): 2950-2962.
  25. Ahmad J., et al. “Solid matrix based lipidic nanoparticles in oral cancer chemotherapy: applications and pharmacokinetics”. Current Drug Metabolism 16.8 (2015): 633-644.
  26. Choy JH., et al. “Cellular uptake behavior of [γ-32P] labeled ATP-LDH nanohybridsElectronic supplementary information (ESI) available: histogram for Mg solubility of Mg2Al-LDH as a function of pH; FITC-LDH exchange rate according to NaCl concentration (FITC= fluorescein 5-isothiocyanate); cytotoxicity test of Mg2Al-NO3−-LDH”. Journal of Materials Chemistry 11.6 (2001): 1671-1674.
  27. Xu ZP., et al. “Dispersion and size control of layered double hydroxide nanoparticles in aqueous solutions”. The Journal of Physical Chemistry B 110.34 (2006): 16923-16929.
  28. Mulvaney P. “Nanoscience vs Nanotechnology Defining the Field”. ACS Publications (2015).
  29. Brust, M., et al. “Synthesis of thiol-derivatised gold nanoparticles in a two-phase liquid-liquid system”. Journal of the Chemical Society, Chemical Communications 7 (1994): 801-802.
  30. Choi O and Z Hu. “Size dependent and reactive oxygen species related nanosilver toxicity to nitrifying bacteria”. Environmental science & technology 42.12 (2008): 4583-4588.
  31. Chen X and HJ Schluesener.” Nanosilver: a nanoproduct in medical application”. Toxicology letters, 176.1 (2008): 1-12.
  32. Prabha S and V Labhasetwar. “Critical determinants in PLGA/PLA nanoparticle-mediated gene expression”. Pharmaceutical Research 21.2 (2004): 354-364.
  33. Alyautdin RN., et al. “Delivery of loperamide across the blood-brain barrier with polysorbate 80-coated poly butyl cyanoacrylate nanoparticles”. Pharmaceutical Research 14.3 (1997): 325-328.
  34. Kreuter J., et al. “Direct evidence that polysorbate-80-coated poly (butylcyanoacrylate) nanoparticles deliver drugs to the CNS via specific mechanisms requiring prior binding of drug to the nanoparticles”. Pharmaceutical Research 20.3 (2003): 409-416.
  35. Danhier F., et al. “PLGA-based nanoparticles: an overview of biomedical applications”. Journal of Controlled Release 161.2 (2012): 505-522.
  36. Murakami H., et al. “Preparation of poly (DL-lactide-co-glycolide) nanoparticles by modified spontaneous emulsification solvent diffusion method”. International Journal of Pharmaceutics 187.2 (1999): 143-152.
  37. Grinstaff MW. “Bio dendrimers: new polymeric biomaterials for tissue engineering”. Chemistry-A European Journal 8.13 (2002): 2838-2846.
  38. Lee CC., et al. “Designing dendrimers for biological applications”. Nature Biotechnology 23.12 (2005): 1517.
  39. West JL and NJ Halas. “Applications of nanotechnology to biotechnology: Commentary”. Current Opinion in Biotechnology 11.2 (2000): 215-217.
  40. Sershen S., et al. “Temperature‐sensitive polymer-nano shell composites for photothermally modulated drug delivery”. Journal of Biomedical Materials Research 51.3 (2000): 293-298.
Citation: Rassol Housen Pure and Mahdi Ghorbani Mazraehkhalfi. “Application of Nanoparticles for Nano Medicine”. EC Pharmacology and Toxicology 8.3 (2020): 01-08.

PubMed Indexed Article


EC Pharmacology and Toxicology
LC-UV-MS and MS/MS Characterize Glutathione Reactivity with Different Isomers (2,2' and 2,4' vs. 4,4') of Methylene Diphenyl-Diisocyanate.

PMID: 31143884 [PubMed]

PMCID: PMC6536005


EC Pharmacology and Toxicology
Alzheimer's Pathogenesis, Metal-Mediated Redox Stress, and Potential Nanotheranostics.

PMID: 31565701 [PubMed]

PMCID: PMC6764777


EC Neurology
Differences in Rate of Cognitive Decline and Caregiver Burden between Alzheimer's Disease and Vascular Dementia: a Retrospective Study.

PMID: 27747317 [PubMed]

PMCID: PMC5065347


EC Pharmacology and Toxicology
Will Blockchain Technology Transform Healthcare and Biomedical Sciences?

PMID: 31460519 [PubMed]

PMCID: PMC6711478


EC Pharmacology and Toxicology
Is it a Prime Time for AI-powered Virtual Drug Screening?

PMID: 30215059 [PubMed]

PMCID: PMC6133253


EC Psychology and Psychiatry
Analysis of Evidence for the Combination of Pro-dopamine Regulator (KB220PAM) and Naltrexone to Prevent Opioid Use Disorder Relapse.

PMID: 30417173 [PubMed]

PMCID: PMC6226033


EC Anaesthesia
Arrest Under Anesthesia - What was the Culprit? A Case Report.

PMID: 30264037 [PubMed]

PMCID: PMC6155992


EC Orthopaedics
Distraction Implantation. A New Technique in Total Joint Arthroplasty and Direct Skeletal Attachment.

PMID: 30198026 [PubMed]

PMCID: PMC6124505


EC Pulmonology and Respiratory Medicine
Prevalence and factors associated with self-reported chronic obstructive pulmonary disease among adults aged 40-79: the National Health and Nutrition Examination Survey (NHANES) 2007-2012.

PMID: 30294723 [PubMed]

PMCID: PMC6169793


EC Dental Science
Important Dental Fiber-Reinforced Composite Molding Compound Breakthroughs

PMID: 29285526 [PubMed]

PMCID: PMC5743211


EC Microbiology
Prevalence of Intestinal Parasites Among HIV Infected and HIV Uninfected Patients Treated at the 1o De Maio Health Centre in Maputo, Mozambique

PMID: 29911204 [PubMed]

PMCID: PMC5999047


EC Microbiology
Macrophages and the Viral Dissemination Super Highway

PMID: 26949751 [PubMed]

PMCID: PMC4774560


EC Microbiology
The Microbiome, Antibiotics, and Health of the Pediatric Population.

PMID: 27390782 [PubMed]

PMCID: PMC4933318


EC Microbiology
Reactive Oxygen Species in HIV Infection

PMID: 28580453 [PubMed]

PMCID: PMC5450819


EC Microbiology
A Review of the CD4 T Cell Contribution to Lung Infection, Inflammation and Repair with a Focus on Wheeze and Asthma in the Pediatric Population

PMID: 26280024 [PubMed]

PMCID: PMC4533840


EC Neurology
Identifying Key Symptoms Differentiating Myalgic Encephalomyelitis and Chronic Fatigue Syndrome from Multiple Sclerosis

PMID: 28066845 [PubMed]

PMCID: PMC5214344


EC Pharmacology and Toxicology
Paradigm Shift is the Normal State of Pharmacology

PMID: 28936490 [PubMed]

PMCID: PMC5604476


EC Neurology
Examining those Meeting IOM Criteria Versus IOM Plus Fibromyalgia

PMID: 28713879 [PubMed]

PMCID: PMC5510658


EC Neurology
Unilateral Frontosphenoid Craniosynostosis: Case Report and a Review of the Literature

PMID: 28133641 [PubMed]

PMCID: PMC5267489


EC Ophthalmology
OCT-Angiography for Non-Invasive Monitoring of Neuronal and Vascular Structure in Mouse Retina: Implication for Characterization of Retinal Neurovascular Coupling

PMID: 29333536 [PubMed]

PMCID: PMC5766278


EC Neurology
Longer Duration of Downslope Treadmill Walking Induces Depression of H-Reflexes Measured during Standing and Walking.

PMID: 31032493 [PubMed]

PMCID: PMC6483108


EC Microbiology
Onchocerciasis in Mozambique: An Unknown Condition for Health Professionals.

PMID: 30957099 [PubMed]

PMCID: PMC6448571


EC Nutrition
Food Insecurity among Households with and without Podoconiosis in East and West Gojjam, Ethiopia.

PMID: 30101228 [PubMed]

PMCID: PMC6086333


EC Ophthalmology
REVIEW. +2 to +3 D. Reading Glasses to Prevent Myopia.

PMID: 31080964 [PubMed]

PMCID: PMC6508883


EC Gynaecology
Biomechanical Mapping of the Female Pelvic Floor: Uterine Prolapse Versus Normal Conditions.

PMID: 31093608 [PubMed]

PMCID: PMC6513001


EC Dental Science
Fiber-Reinforced Composites: A Breakthrough in Practical Clinical Applications with Advanced Wear Resistance for Dental Materials.

PMID: 31552397 [PubMed]

PMCID: PMC6758937


EC Microbiology
Neurocysticercosis in Child Bearing Women: An Overlooked Condition in Mozambique and a Potentially Missed Diagnosis in Women Presenting with Eclampsia.

PMID: 31681909 [PubMed]

PMCID: PMC6824723


EC Microbiology
Molecular Detection of Leptospira spp. in Rodents Trapped in the Mozambique Island City, Nampula Province, Mozambique.

PMID: 31681910 [PubMed]

PMCID: PMC6824726


EC Neurology
Endoplasmic Reticulum-Mitochondrial Cross-Talk in Neurodegenerative and Eye Diseases.

PMID: 31528859 [PubMed]

PMCID: PMC6746603


EC Psychology and Psychiatry
Can Chronic Consumption of Caffeine by Increasing D2/D3 Receptors Offer Benefit to Carriers of the DRD2 A1 Allele in Cocaine Abuse?

PMID: 31276119 [PubMed]

PMCID: PMC6604646


EC Anaesthesia
Real Time Locating Systems and sustainability of Perioperative Efficiency of Anesthesiologists.

PMID: 31406965 [PubMed]

PMCID: PMC6690616


EC Pharmacology and Toxicology
A Pilot STEM Curriculum Designed to Teach High School Students Concepts in Biochemical Engineering and Pharmacology.

PMID: 31517314 [PubMed]

PMCID: PMC6741290


EC Pharmacology and Toxicology
Toxic Mechanisms Underlying Motor Activity Changes Induced by a Mixture of Lead, Arsenic and Manganese.

PMID: 31633124 [PubMed]

PMCID: PMC6800226


EC Neurology
Research Volunteers' Attitudes Toward Chronic Fatigue Syndrome and Myalgic Encephalomyelitis.

PMID: 29662969 [PubMed]

PMCID: PMC5898812


EC Pharmacology and Toxicology
Hyperbaric Oxygen Therapy for Alzheimer's Disease.

PMID: 30215058 [PubMed]

PMCID: PMC6133268


News and Events


April Issue Release

We always feel pleasure to share our updates with you all. Here, notifying you that we have successfully released the April issue of respective journals and the latest articles can be viewed on the current issue pages.

Submission Deadline for upcoming Issue

Ecronicon delightfully welcomes all the authors around the globe for effective collaboration with an article submission for the upcoming issue of respective journals. Submissions are accepted on/before May 04, 2021.

Certificate of Publication

Ecronicon honors with a "Publication Certificate" to the corresponding author by including the names of co-authors as a token of appreciation for publishing the work with our respective journals.

Best Article of the Issue

Editors of respective journals will always be very much interested in electing one Best Article after each issue release. The authors of the selected article will be honored with a "Best Article of the Issue" certificate.

Certifying for Review

Ecronicon certifies the Editors for their first review done towards the assigned article of the respective journals.

Latest Articles

The latest articles will be updated immediately on the articles in press page of the respective journals.

Immediate Assistance

The prime motto of this team is to clarify all the queries without any delay or hesitation to avoid the inconvenience. For immediate assistance on your queries please don't hesitate to drop an email to editor@ecronicon.uk